However, the overall clinical benefit still requires careful consideration, because the cGAS/STING pathway, which is induced in response to cytosolic DNA generated by genomic instability, is also associated with immune responses that have anti-tumor effects [23, 36]. The gene discussed is CGAS; the disease is neoplasm.